Profluent Bio vs Opentrons

Side-by-side comparison of AI visibility scores, market position, and capabilities

Opentrons leads in AI visibility (72 vs 36)
Profluent Bio logo

Profluent Bio

EmergingBiotechnology

AI Protein Design

AI protein design company released OpenCRISPR-1, the first gene editor designed entirely by AI; raised $35M developing novel enzymes, antibodies, and gene-editing tools by exploring protein sequence space beyond what evolution has produced.

AI VisibilityBeta
Overall Score
D36
Category Rank
#94 of 198
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
40
Perplexity
33
Gemini
37

About

Profluent Bio is an AI protein design company founded in 2022 by former Meta AI researcher Ali Madani, raising $35M in seed and Series A funding. The company trains large generative models on biological sequence data to design novel proteins with specific structural and functional properties, analogous to how large language models generate text. Profluent made scientific history in 2024 by publishing OpenCRISPR-1, the first gene editor designed entirely by AI rather than adapted from natural organisms, which the company released open source for non-commercial research. The platform enables design of novel enzymes, antibodies, and gene-editing tools by exploring protein sequence space far beyond what evolution has produced. Profluent works with pharmaceutical and agricultural biotechnology companies that need custom protein tools for research and therapeutic development. The company represents a fundamental advance in moving protein engineering from directed evolution and rational design toward generative AI-driven discovery.

Full profile
Opentrons logo

Opentrons

LeaderLife Sciences & BioTech

Lab Automation & Liquid Handling Robotics

Opentrons democratizes lab automation with 10,000+ OT-2 and Flex robotic systems deployed globally; raised $200M+ including $20M Series C in Nov 2025; partnered with BD and HighRes for AI agent-to-agent workflows.

AI VisibilityBeta
Overall Score
B72
Category Rank
#16 of 198
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
73
Gemini
68

About

Opentrons Labworks is a New York-based life sciences company that designs and manufactures affordable, open-source liquid-handling robots for research laboratories. Founded in 2014, Opentrons'' mission is to democratize biology by making advanced lab automation accessible to life scientists at any institution — from academic labs with limited budgets to leading pharmaceutical companies. Its flagship products, the OT-2 and the newer Opentrons Flex, are programmable robotic platforms that automate repetitive liquid-handling tasks such as PCR setup, nucleic acid extraction, ELISA assays, and next-generation sequencing sample preparation.

Full profile

AI Visibility Head-to-Head

36
Overall Score
72
#94
Category Rank
#16
79
AI Consensus
79
stable
Trend
stable
40
ChatGPT
76
33
Perplexity
73
37
Gemini
68
32
Claude
68
38
Grok
73

Key Details

Category
AI Protein Design
Lab Automation & Liquid Handling Robotics
Tier
Emerging
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Profluent Bio
AI Protein Design

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.